Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001766764 | SCV002008726 | pathogenic | not provided | 2024-05-08 | criteria provided, single submitter | clinical testing | De novo variant with confirmed parentage in a patient referred for genetic testing at GeneDx; however, the reported clinical features are only partially consistent with the features typically observed in individuals with pathogenic variants in this gene; Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 31138930, 34328347) |
Labcorp Genetics |
RCV002536179 | SCV002953765 | uncertain significance | Aortic valve disease 2 | 2022-05-30 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 690410). This premature translational stop signal has been observed in individual(s) with SMAD6-related conditions (PMID: 31138930). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg75*) in the SMAD6 gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in SMAD6 cause disease. |
The Laboratory of Genetics and Metabolism, |
RCV000851345 | SCV000993649 | pathogenic | Radioulnar synostosis | 2019-05-14 | no assertion criteria provided | case-control | PVS1, PM2, PP3, PP4 |